Publications Using CPCTR Materials

  1. Isharwal S, Miller MC, Marlow C, Makarov DV, Partin AW, Veltri RW. p300 (Histone Acetyltransferase) Biomarker Predicts Prostate Cancer Biochemical Recurrence and Correlates With Changes in Epithelia Nuclear Size and Shape. Prostate. 2008 Jul 1;68(10):1097-104. Article (.pdf, 150kb)
  2. Veltri RW, Miller MC, Isharwal S, Marlow C, Makarov DV, Partin AW. Prediction of Prostate-Specific Antigen Recurrence in Men with Long-term Follow-up Postprostatectomy Using Quantitative Nuclear Morphometry. Cancer Epidemiol Biomarkers Prev 2008;17(1). January 2008. Article (.pdf, 400kb)
  3. Veltri, R. W., Miller, M. C., Isharwal, S., Marlow, C., Makarov, D.V., Partin, A. W. Prediction of Prostate-Specific Antigen Recurrence in Men with Long-term Follow-up Postprostatectomy Using Quantitative Nuclear Morphometry Cancer Epidemiol Biomarkers Prev 2008 17: p. 102-110. PMID: 18199716 [PubMed -indexed for MEDLINE]
  4. Abdul M, Hoosein N. N-methyl-D-aspartate receptor in human prostate cancer. Journal of Membrane Biology 2005; 205(3):125-128.
  5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-66.
  6. Liu P, Ramachandran S, Seyed MA, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL, Moreno CS. Sex-determining Region Y Box 4 is a transforming oncogene in human prostate cancer cells. Cancer Research 2006; 66:4011-4019.
  7. Christopher M. Heaphy, William C. Hines, Kimberly S. Butler, Christina M. Haaland, Glenroy Heywood, Edgar G. Fischer, Marco Bisoffi, and Jeffrey K. Griffith. Assessment of the Frequency of Allelic Imbalance in Human Tissue Using a Multiplex Polymerase Chain Reaction System. J. Mol. Diagn. 2007 9: 266-271.
  8. Turley, Ryan S., Finger, Elizabeth C., Hempel, Nadine, How, Tam, Fields, Timothy A., Blobe, Gerard C. The Type III Transforming Growth Factor Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer. Cancer Res 2007 67: 1090-1098.
  9. Bair EL, Nagle RB, Ulmer TA, Laferté S, Bowden GT. 90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression. Prostate. 2006 Feb 15;66(3):283-93.
  10. Cao X, Qin J, XieY ,Khan O, Dowd F, Scofield M, Lin M-F and Tu Y. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells. Oncogene 2006 25, 3719Ð3734.
  11. Improved prediction of PSA biochemical recurrence by quantitative nuclear grade (QNG) Using the NCI CPCTR-prostate tissue microarray Cameron Marlow, Alan W. Partin and Robert W. Veltri. Amer Assoc Cancer Res, Volume 47, 2006.
  12. A microRNA expression signature of human solid tumors defines cancer gene targets Stefano Volinia, George A. Calin, Chang-Gong Liu, Stefan Ambs, Amelia Cimmino, Fabio Petrocca, Rosa Visone, Marilena Iorio, Claudia Roldo, Manuela Ferracin, Robyn L. Prueitt, Nozumu Yanaihara, Giovanni Lanza, Aldo Scarpa, Andrea Vecchione, Massimo Negrini, Curtis C. Harris, and Carlo M. Croce. February 14, 2006. PNAS, vol. 103, no. 7, 2257-2261.
  13. WWOX protein expression in prostate carcinoma Maria Ines Nunez, Martin C. Abba, Joshua D. Liao, and C. Marcelo Aldaz. Amer Assoc Cancer Res, Volume 46, 2005.